마이크로캐리어 시장 규모, 점유율, 동향 분석 보고서 : 소모품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Microcarriers Market Summary

The global microcarriers market size was estimated at USD 2.13 billion in 2025 and is projected to reach USD 4.89 billion by 2033, growing at a CAGR of 11.18% from 2026 to 2033. The growth of the microcarriers industry is attributed to the high demand for cell-based vaccines & therapeutics, the increasing incidence of various diseases & disorders such as diabetes, cancer, rheumatoid arthritis, hemophilia, and others, huge investments for the development of innovative therapies, and consistent technological advancements in cell biology research.

For instance, in May 2024, Sartorius and Sanofi partnered to develop and commercialize a platform that streamlines and optimizes downstream bioprocessing operations, enhancing efficiency and productivity in the production of biopharmaceuticals. This can lead to the development of more sophisticated microcarrier-based bioprocessing technologies.

Global Microcarriers Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global microcarriers market report based on the consumable, application, end use, and region:

• Consumable Outlook (Revenue, USD Million, 2021 - 2033)
• Media & Reagents
• Microcarrier Beads
  • Collagen Coated Beads
  • Cationic Beads
  • Protein Coated Beads
  • Untreated Beads
  • Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Biopharmaceutical Production
  • Vaccine Production
  • Therapeutic Production
• Regenerative Medicine
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations & Contract Manufacturing Organizations
• Academic & Research Institutes
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definition
  • 1.2.1. Consumable
  • 1.2.2. Application
  • 1.2.3. End Use
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
• 1.7. Primary Research
• 1.8. Information or Data Analysis
• 1.9. Market Formulation & Validation
• 1.10. Market Model
• 1.11. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Microcarriers Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. High demand of cell-based vaccines & therapeutics
    • 3.2.1.2. Rising incidence of chronic diseases & disorders
    • 3.2.1.3. Increasing investments for development of innovative therapies
    • 3.2.1.4. Recent technological advancements in cell biology research
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of research for cell based drug and therapy
    • 3.2.2.2. High cost of downstream processing
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis

Chapter 4. Microcarriers Market: Consumable Estimates & Trend Analysis

• 4.1. Consumable Movement Analysis & Market Share, 2025 & 2033
• 4.2. Microcarriers Market Estimates & Forecast, By Consumable, 2021 to 2033 (USD Million)
• 4.3. Media and Reagents
  • 4.3.1. Media and Reagents Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.4. Microcarrier Beads
  • 4.4.1. Microcarrier Beads Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Collagen Coated Beads
    • 4.4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Cationic Beads
    • 4.4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.4. Protein Coated Beads
    • 4.4.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.5. Untreated Beads
    • 4.4.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.6. Others
    • 4.4.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Microcarriers Market: Application Estimates & Trend Analysis

• 5.1. Application Movement Analysis & Market Share, 2025 & 2033
• 5.2. Microcarriers Market Estimates & Forecast, By Application, 2021 to 2033 (USD Million)
• 5.3. Biopharmaceutical Production
  • 5.3.1. Biopharmaceutical Production Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3.2. Vaccine Production
    • 5.3.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3.3. Therapeutic Production
    • 5.3.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.4. Regenerative Medicine
  • 5.4.1. Regenerative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Microcarriers Market: End Use Estimates & Trend Analysis

• 6.1. End Use Movement Analysis & Market Share, 2025 & 2033
• 6.2. Microcarriers Market Estimates & Forecast, By End Use, 2021 to 2033 (USD Million)
• 6.3. Pharmaceutical & Biotechnology Companies
  • 6.3.1. Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.4. Contract Research Organizations (CRO)s & Contract Manufacturing Organizations (CMO)s
  • 6.4.1. CROs & CMOs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Academic & Research Institutes
  • 6.5.1. Academic & Research Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Microcarriers Market: Regional Estimates & Trend Analysis by Consumable, Application and End Use

• 7.1. Regional Dashboard
• 7.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
• 7.3. North America
  • 7.3.1. North America market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key country dynamics
    • 7.3.4.2. Regulatory framework
    • 7.3.4.3. Competitive scenario
    • 7.3.4.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.4.7. Denmark
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.4.8. Sweden
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key country dynamics
    • 7.4.9.2. Regulatory framework
    • 7.4.9.3. Competitive scenario
    • 7.4.9.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.5.3. China
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.5.5. Australia
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.5.6. South Korea
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Regulatory framework
    • 7.5.7.3. Competitive scenario
    • 7.5.7.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
• 7.7. MEA
  • 7.7.1. MEA market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Regulatory framework
    • 7.7.5.3. Competitive scenario
    • 7.7.5.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company/Competition Categorization
• 8.2. Key company market position analysis, 2025
• 8.3. Company Overview
  • 8.3.1. Thermo Fisher Scientific, Inc.
    • 8.3.1.1. Company overview
    • 8.3.1.2. Financial performance
    • 8.3.1.3. Product benchmarking
    • 8.3.1.4. Strategic initiatives
  • 8.3.2. Merck KGaA
    • 8.3.2.1. Company overview
    • 8.3.2.2. Financial performance
    • 8.3.2.3. Product benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. Danaher Corporation
    • 8.3.3.1. Company overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Product benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. Sartorius AG
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Corning Incorporated
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Eppendorf SE
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Bio-Rad Laboratories, Inc.
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. HiMedia Laboratories Pvt. Ltd.
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. DenovoMATRIX GmbH
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives